Mineralys Therapeutics, Inc. Announces Annual Meeting of Stockholders

TL;DR

<b>Mineralys Therapeutics, Inc. will hold its annual stockholder meeting online on May 22, 2024, with proxy materials available online.</b>

AI Summary

Mineralys Therapeutics, Inc. (MLYS) filed a Proxy Statement (DEF 14A) with the SEC on April 9, 2024. Annual meeting scheduled for May 22, 2024, at 12:00 p.m. Eastern Time. Meeting will be held solely online via a live webcast for ease of access and participation. Companies can furnish proxy materials to stockholders by providing access to documents on the Internet. This method lowers delivery costs and reduces environmental impact. Stockholders can vote via the Internet, telephone, or by returning a signed proxy card.

Why It Matters

For investors and stakeholders tracking Mineralys Therapeutics, Inc., this filing contains several important signals. The company is leveraging SEC rules to provide proxy materials online, reducing costs and environmental impact. Encouraging stockholders to vote online, by phone, or by mail to ensure their vote is counted.

Risk Assessment

Risk Level: low — Mineralys Therapeutics, Inc. shows low risk based on this filing. The filing is a routine DEF 14A proxy statement, indicating standard corporate governance procedures rather than significant new developments.

Analyst Insight

Stockholders should review the proxy materials for information on matters to be voted on at the annual meeting and cast their votes accordingly.

Key Numbers

• 2024-05-22 — Annual Meeting Date (Date of the annual meeting of stockholders)
• 12:00 p.m. — Annual Meeting Time (Time of the annual meeting of stockholders)
• 1934 Act — SEC Act (Governing SEC Act for the filing)

Key Players & Entities

• Mineralys Therapeutics, Inc. (company) — Registrant
• May 22, 2024 (date) — Annual meeting date
• 12:00 p.m. (time) — Annual meeting time
• Eastern Time (time) — Annual meeting time zone
• 1934 Act (regulation) — SEC Act
• 150 N. Radnor Chester Road (address) — Business address
• Radnor, PA (address) — Business address
• 19087 (zip_code) — Business address zip code

FAQ

Industry Context

Mineralys Therapeutics, Inc. is a pharmaceutical company. This filing is a standard proxy statement for its annual stockholder meeting.

Regulatory Implications

The filing is made pursuant to Section 14(a) of the Securities Exchange Act of 1934, which governs the solicitation of proxies from stockholders.

What Investors Should Do

1. Review the proxy materials for details on proposals to be voted on at the annual meeting.
2. Vote your shares by the deadline, using the provided online, telephone, or mail options.
3. Ensure your vote is counted by submitting it in advance if you cannot attend the virtual meeting.

Key Dates

• 2024-05-22: Annual Meeting of Stockholders — Key date for stockholder participation and voting.

Year-Over-Year Comparison

This is a DEF 14A filing, which is a standard proxy statement and does not represent a change from previous filings in terms of material events.

Key Financial Figures

• $15,000 — ing. We will pay Alliance a base fee of $15,000, plus reasonable out-of-pocket expenses
• $20,000 — yable to Alliance will be approximately $20,000. We will then reimburse them for their

Filing Documents

• mlys-proxystatementx202404.htm (DEF 14A) — 396KB
• card1a.jpg (GRAPHIC) — 194KB
• card2a.jpg (GRAPHIC) — 304KB
• card3a.jpg (GRAPHIC) — 127KB
• card4a.jpg (GRAPHIC) — 900KB
• image_2a.jpg (GRAPHIC) — 33KB
• logoa.jpg (GRAPHIC) — 23KB
• picture2a.jpg (GRAPHIC) — 28KB
• 0001933414-24-000009.txt (&nbsp;) — 2610KB

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 20 EXECUTIVE AND DIRECTOR COMPENSATION 22 CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS 30 STOCKHOLDER PROPOSALS 33 ANNUAL REPORT 34 STOCKHOLDERS SHARING THE SAME ADDRESS 34 OTHER MATTERS 34 150 N. Radnor Chester Rd, Suite F200 Radnor, PA 19087 PROXY STATEMENT FOR THE 2024 ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON WEDNESDAY, MAY 22, 2024 The board of directors of Mineralys Therapeutics, Inc. is soliciting the enclosed proxy for use at the annual meeting of stockholders, including at any adjournments or postponements of the meeting, to be held virtually on May 22, 2024 at 1200 p.m., Eastern Time. In this proxy statement, "Mineralys," the "Company," "we," "us," and "our" refer to Mineralys Therapeutics, Inc. We have elected to take advantage of Securities and Exchange Commission rules that allow companies to furnish proxy materials to their stockholders by providing access to these documents on the Internet instead of mailing printed copies. Those rules allow a company to provide its stockholders with the information they need, while lowering the costs of delivery and reducing the environmental impact of the annual meeting. Most of our stockholders will not receive printed copies of our proxy materials unless requested, but instead will receive a notice with instructions on how they may access and review our proxy materials on the Internet and how they may cast their vote via the Internet. If you would like to receive a printed or e-mail copy of our proxy materials, please follow the instructions for requesting the materials in the Notice of Internet Availability of Proxy Materials that is being sent to you. To attend the annual meeting, you must register at www.virtualshareholdermeeting.comMLYS2024 by 1200 p.m., Eastern Time on May 22, 2024. Upon completing your registration, you will receive further instructions via email, including a unique link that will allow you

View Full Filing

View this DEF 14A filing on SEC EDGAR